BENSALEM, Pa.–Law Offices of Howard G. Smith announces that it is investigating potential claims against the board of directors of Zygo Corporation (“Zygo” or the “Company”) (NASDAQ:ZIGO) related to an unsolicited purchase offer the Company received from II-VI Incorporated (“II-VI”), a manufacturer of specialty optical components, to acquire all of the outstanding shares of Zygo […]
LARCHMONT, N.Y.–LadaTech announced today that it has served its complaint upon Illumina, Inc. in its lawsuit for patent infringement in the United States District Court for the District of Delaware. LadaTech is jointly owned by GlaxoSmithKline and IP Finance Holdings. LadaTech’s lawsuit is for the infringement of United States Patent No. 6,107,023, which issued on […]
Investigation Leads the Company to Believe Sequenom Willfully Manipulated its Down Syndrome Data in its Presentations NEW YORK–Xenomics, Inc. (XNOM.PK), a developer of transrenal molecular diagnostics, announced today that an ongoing internal investigation by Xenomics’ personnel of the events surrounding its licensing deal with Sequenom (Nasdaq:SQNM) in late October, 2008 leads it to conclude that […]
HAMBURG, Germany — Eppendorf has initiated an import ban for Nanosphere, Inc.’s Verigene(R) and Verigene(R) SP systems for infringement of European patent EP 1 179 180 B2, titled “Method for the identification and/or the quantification of a target compound”. The import ban covers any and all imports of the respective products into any country of […]
RESEARCH TRIANGLE PARK, N.C.–Yesterday, the European Patent Office (EPO) revoked previously granted claims of Cellectis’ European Patent No. EP 1485475 during an oral hearing in an opposition proceeding initiated by Precision BioSciences. As a result of the opposition, Cellectis’ previously granted claims to single-chain meganucleases, including those derived from I-CreI, were revoked in their entirety. […]
NEW YORK — Xenomics, Inc. (Pink Sheets:XNOM.PK)(FWB:XE7) a developer of trans-renal molecular diagnostic technologies, announced today that it has filed a complaint against Sequenom, Inc. (Nasdaq: SQNM) in the Supreme Court of the State of New York alleging that Sequenom fraudulently misrepresented to Xenomics the status of its testing for Down Syndrome and based upon […]
USPTO reaffirms the validity of core SpliceArray™ patent ExonHit (Paris:ALEHT) is pleased to announce that the United States Patent and Trademark Office (“USPTO”) notified the Company of its intent to issue a Re-examination Certificate in connection with ExonHit’s US Patent n° 6,881,571 directed to the use of its SpliceArray™ technology. The validity of this patent […]
SAN DIEGO — Illumina, Inc. (Nasdaq:ILMN) today announced that, together with Solexa its wholly owned subsidiary, it has filed its initial response to the lawsuit brought by Life Technologies and Applied Biosystems on September 21, 2009 in U.S. District Court in Wilmington, Delaware. In their answer, Illumina and Solexa have denied all of Life’s and […]
MUKILTEO, Wash. — CombiMatrix Corporation (Nasdaq:CBMX – News) today announced that the U.S. 9th Circuit Court of Appeals (the “Court”) has set a date for an oral hearing in its litigation with National Union Fire Insurance Company of Pittsburgh, PA, an AIG company (NYSE:AIG – News). This oral hearing is a short session (each side […]
Precision BioSciences Announces U.S. Patent Office Reexamination of Cellectis Patents Involved in Litigation RESEARCH TRIANGLE PARK, N.C.– Precision BioSciences, Inc. today announced that the United States Patent and Trademark Office (PTO) has granted Precision’s requests for inter partes reexamination of U.S. Patent Nos. 6,610,545 (the ‘545 patent) and 7,309,605 (the ‘605 patent), which Cellectis SA […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
